GESTIÓN EN SALUD PÚBLICA: Funding News from Fogarty Int'l Center at NIH

miércoles, 9 de enero de 2019

Funding News from Fogarty Int'l Center at NIH

Funding news for global health researchers and partners from Fogarty at NIH

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional) (RFA-CA-19-009)
The U.S.-China Program for Biomedical Collaborative Research aims to stimulate collaborative basic, translational and clinical research between U.S.-based researchers and Chinese researchers in the areas of cancer, environmental health, heart disease, blood disorders, diseases of the eye and visual system, mental health and neurological disorders.
Application Receipt Date(s): February 21, 2019
Reminder: Invitation to develop case examples of health research in humanitarian contexts as a part of the Advancing Health Research in Humanitarian Crises project, led by Fogarty's Center for Global Health Studies. When needed, financial support up to $5,000 per case will be made available to support the development of the cases.
Receipt deadline: January 21, 2019

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

Revision Application for Implementation Research to Inform and Enhance PEPFAR HIV Pre-exposure Prophylaxis (PrEP) Delivery (R01 Clinical Trial Optional) (RFA-MH-19-425)
Application Receipt Date(s): February 18, 2019
Resources for Technology Dissemination (U24 Clinical Trial Not Allowed) (RFA-EB-18-002)
Application Receipt Date(s): February 27, 2019
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) (PA-19-111) and (R01 Clinical Trial Optional) (PA-19-112)
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) (PAR-19-113)
Application Receipt/Submission Date(s): Standard dates apply
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) (PAR-19-136)
Application Receipt/Submission Date(s): Standard dates apply
NEI Audacious Goals Initiative: Preliminary Studies for Translation-Enabling Models of the Visual System (R21 Clinical Trial Not Allowed) (RFA-EY-19-001)
Application Receipt Date(s): March 8, 2019

NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.

Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed) (RFA-DA-19-030) and (R43/R44 - Clinical Trial Not Allowed) (RFA-DA-19-031)
Application Receipt Date(s): March 4, 2019

Funding News

NIH funding news that may be relevant to global health researchers.

NIH Implementation of the Final Rule on the Federal Policy for the Protection of Human Subjects (Common Rule) (NOT-OD-19-050)
Request for Information (RFI): NICHD Strategic Plan Fiscal Years 2020-2024 (NOT-HD-18-031)
Notice of 3 Pre-Application Webinars for NCCIH HEAL Funding Opportunity Announcements (NOT-AT-19-019)
Notice of Interest in Advancing Research in Acute Flaccid Myelitis and Guillain-Barre Syndrome (NOT-NS-19-029)
Notices to Specify High-Priority Research Topic for Research on Current Topics in Alzheimer's Disease and Its Related Dementias PAR-19-070 and PAR-19-071 (NOT-AG-18-056) and (NOT-AG-18-057)
Request for Proposals (RFP) Notice: Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders (NOT-DA-19-060)